专利号:US-9353140-B2 优先权日:2009-11-25 标 题:BQC-G, a tumor-selective anti-cancer prodrug 发明人:PRIJOVIC ZELJKO M; LEU YU-LIN; ROFFLER STEVE R 权利人:PRIJOVIC ZELJKO M; LEU YU-LIN; ROFFLER STEVE R; ACADEMIA SINICA 摘要:The invention relates to the synthesis of a second-generation camptothecin glucuronide prodrug (BQC-G) of a potent anticancer camptothecin derivative 5,6-dihydro-4H-benzo[de]quinoline-camptothecin (BQC). BQC-G was over 4000 times more water soluble than BQC, displayed good stability in human plasma and was an excellent substrate for enzymatic hydrolysis by bacterial and human β-glucuronidases. BQC-G was about 30 times less toxic than BQC, but was as toxic as BQC after hydrolysis of the glucuronide moiety by β-glucuronidase. In the presence of human serum albumin, BQC-G displayed lower cytotoxicity (IC 50 =1080 nM) but could be activated by β-glucuronidase to display potent activity (IC 50 =13.3 nM).
专利号:FR-2586687-A1 优先权日:1985-08-30 标题 :SYNTHESIS PROCESS AND NOVEL DERIVATIVES OF A, L-IDURONIC ACID
[参考文献]: Y L Leu, Et Al. Design And Synthesis Of Water-Soluble Glucuronide Derivatives Of Camptothecin For Cancer Prodrug Monotherapy And Antibody-Directed Enzyme Prodrug Therapy (Adept). J Med Chem. 1999 Sep 9;42(18):3623-8.
合成参考文献
摘要:Kryczka, B.; Lewkowski, J.; Zawisza, A., Science of Synthesis, (2007) 29, 1015.